Tag Archives: Platinum-based Drugs Market

Platinum-based Drugs Market To 2019 Top Industry Players, Revenue By 2026

Platinum-based drugs contain coordinated complexes of platinum. These are widely used in the treatment of cancer as chemotherapeutic agents. Platinum acts as cell damaging agent for certain cancer treatments. Approximately 10% to 20% patients treated with chemotherapy receive platinum-based drugs. These drugs are used either alone or in combination with other drug treatment. Rise in prevalence of cancer is a major driver of the ****** platinum-based drugs market. According to the National Cancer Institute, the number of new cancer cases per year is expected to rise to 23.6 million by 2030. However, side effects associated with the drugs and development of resistance for the drug are the major restraints of the ****** platinum-based drugs market. Recent trends in platinum-based drugs include development of platinum drugs analog such as platinum complexes with carrier molecule in order to increase targeted concentration of drug in cancer tumor.